Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Lehmann

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
The Journal of Biological Chemistry|February 7, 1997
Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathwayJ M Lehmann, S A Kliewer, L B Moore, et al.
Cell|March 7, 1998
An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathwayS A Kliewer, J T Moore, L Wade, et al.
Molecular Cell|April 13, 1999
Molecular recognition of fatty acids by peroxisome proliferator-activated receptorsH E Xu, M H Lambert, V G Montana, et al.
Journal of Medicinal Chemistry|October 3, 1999
A ureido-thioisobutyric acid (GW9578) is a subtype-selective PPARalpha agonist with potent lipid-lowering activityP J Brown, D A Winegar, K D Plunket, et al.
Journal of Lipid Research|October 9, 2001
Effects of fenofibrate on lipid parameters in obese rhesus monkeysD A Winegar, P J Brown, W O Wilkison, et al.
Chemistry & Biology|March 7, 1998
Identification of peroxisome proliferator-activated receptor ligands from a biased chemical libraryP J Brown, T A Smith-Oliver, P S Charifson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 1999
A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiationJ L Oberfield, J L Collins, C P Holmes, et al.
Diabetes|July 2, 1999
A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty ratK K Brown, B R Henke, S G Blanchard, et al.
Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agentsB R Henke, S G Blanchard, M F Brackeen, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
The Journal of Biological Chemistry|February 7, 1997
Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathwayJ M Lehmann, S A Kliewer, L B Moore, et al.
Cell|March 7, 1998
An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathwayS A Kliewer, J T Moore, L Wade, et al.
Molecular Cell|April 13, 1999
Molecular recognition of fatty acids by peroxisome proliferator-activated receptorsH E Xu, M H Lambert, V G Montana, et al.
Journal of Medicinal Chemistry|October 3, 1999
A ureido-thioisobutyric acid (GW9578) is a subtype-selective PPARalpha agonist with potent lipid-lowering activityP J Brown, D A Winegar, K D Plunket, et al.
Journal of Lipid Research|October 9, 2001
Effects of fenofibrate on lipid parameters in obese rhesus monkeysD A Winegar, P J Brown, W O Wilkison, et al.
Chemistry & Biology|March 7, 1998
Identification of peroxisome proliferator-activated receptor ligands from a biased chemical libraryP J Brown, T A Smith-Oliver, P S Charifson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 1999
A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiationJ L Oberfield, J L Collins, C P Holmes, et al.
Diabetes|July 2, 1999
A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty ratK K Brown, B R Henke, S G Blanchard, et al.
Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agentsB R Henke, S G Blanchard, M F Brackeen, et al.
Pageof 6